SAN ANTONIO: A court has ruled that drug manufacturer Actavis PLC’s attempted switch of patented Alzheimer’s medication, which halted distribution of the old drug before its patent expires this summer, violates antitrust law.

The decision unsealed this week explains the ruling last week by a Read More »

BALTIMORE: Investigators recently discovered that the most significant genetic risk factor associated with Alzheimer’s disease, the Apolipoprotein E4 (ApoE4) gene, leads to a decrease in brain synapses, which occurs frequently prior to the onset of amyloid plaques or tangles developing in Alzheimer’s patients. This discovery Read More »

CHICAGO: A new study found that patients with dementia show a decrease in sexual relations with their partners.

The study focused specifically on patients with frontotemporal dementia (FTD), the second most common cause of young-onset dementia (aged less than 65 years), which is typically associated Read More »

DETROIT: A university has unveiled proposed changes to the way it protects human subjects in research.

An “implementation team” formed in March — made up of outside experts, University faculty members and administrators — outlined a beefed-up human research subjects protection program to the public Read More »